Microbion Corp-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Microbion Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014180
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Microbion Corp (Microbion) is a clinical stage biopharmaceutical company which develops therapeutic products. The company develops products for the treatment of antibiotic-resistant infections and control of microbial biofilms. It develops environmentally responsible solutions to prevent microbial biofilms and the associated biofouling and biocorrosion produced in a various industrial processes. Microbion develops products using its bismuth-thiol platform technology. The company’s therapeutic pipeline includes BT compounds for the treatment of chronic and acute wound infections and post-surgical orthopedic infections. It also offers antimicrobial and antibiofilm therapeutics and medical device coating solutions. The company serves healthcare industries. Microbion is headquartered in Bozeman, Montana, the US.

Microbion Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Microbion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Microbion Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Microbion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Microbion Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Microbion Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Microbion Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Microbion Raises USD25 Million in Venture Financing 10
Microbion Raises US$0.1 Million In Venture Financing 11
Microbion Raises US$1.25 Million In Venture Financing 12
Microbion Raises Additional US$0.7 Million In Venture Financing 13
Partnerships 14
Microbion Enters into Agreement with Xizang Haisco Pharma 14
Equity Offering 15
Microbion Raises Funds through Private Placement of Shares 15
Microbion Corp – Key Competitors 16
Microbion Corp – Key Employees 17
Microbion Corp – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Microbion Corp, Pharmaceuticals & Healthcare, Key Facts 2
Microbion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Microbion Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Microbion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Microbion Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Microbion Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Microbion Raises USD25 Million in Venture Financing 10
Microbion Raises US$0.1 Million In Venture Financing 11
Microbion Raises US$1.25 Million In Venture Financing 12
Microbion Raises Additional US$0.7 Million In Venture Financing 13
Microbion Enters into Agreement with Xizang Haisco Pharma 14
Microbion Raises Funds through Private Placement of Shares 15
Microbion Corp, Key Competitors 16
Microbion Corp, Key Employees 17
Microbion Corp, Other Locations 18

★海外企業調査レポート[Microbion Corp-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sigla, S.A.:企業の戦略的SWOT分析
    Sigla, S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Papeles y Cartones de Europa SA:企業の戦略・SWOT・財務情報
    Papeles y Cartones de Europa SA - Strategy, SWOT and Corporate Finance Report Summary Papeles y Cartones de Europa SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Cosumar SA:戦略・SWOT・企業財務分析
    Cosumar SA - Strategy, SWOT and Corporate Finance Report Summary Cosumar SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Elektro Eletricidade E Servicos SA (EKTR3):電力:M&Aディール及び事業提携情報
    Summary Elektro Eletricidade E Servicos SA (Elektro Eletricidade) is an electric energy distributor that offers power supply and utility services. The company provides electric services to home, business and public environments. It offers services such as electricity bill, debits, change due, accoun …
  • Mgm China Holdings Ltd
    Mgm China Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Mgm China Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bionomics Ltd (BNO):企業の財務・戦略的SWOT分析
    Summary Bionomics Ltd (Bionomics) is a biopharmaceutical company that discovers and develops treatments for cancer, and central nervous system disorders such as anxiety, depression and Alzheimer's disease. The company provides pipeline products such as BNC210, BNC 105, BNC101 and BNC375, among other …
  • Heron Therapeutics Inc (HRTX)-製薬・医療分野:企業M&A・提携分析
    Summary Heron Therapeutics Inc (Heron), formerly A.P. Pharma, Inc., is a biotechnology company that uses its proprietary polymer-based drug delivery platform to develop novel, patient-focused therapeutic products for patients suffering from cancer and pain. Its proprietary Biochronomer technology is …
  • Metsa Tissue Corp:企業の戦略的SWOT分析
    Metsa Tissue Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Bahrain Telecommunications Company BSC (BATELCO):企業の戦略的SWOT分析
    Bahrain Telecommunications Company BSC (BATELCO) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • Wienerberger AG:企業のM&A・事業提携・投資動向
    Wienerberger AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wienerberger AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Chattem Inc:企業の戦略・SWOT・財務情報
    Chattem Inc - Strategy, SWOT and Corporate Finance Report Summary Chattem Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Web.com Group, Inc.:企業の戦略的SWOT分析
    Web.com Group, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Houghton Mifflin Harcourt Company:企業のM&A・事業提携・投資動向
    Houghton Mifflin Harcourt Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Houghton Mifflin Harcourt Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • DUAL International Ltd:企業の戦略・SWOT・財務情報
    DUAL International Ltd - Strategy, SWOT and Corporate Finance Report Summary DUAL International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • The Scotts Miracle-Gro Company (SMG):企業の財務・戦略的SWOT分析
    The Scotts Miracle-Gro Company (SMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • ReWalk Robotics Ltd (RWLK):医療機器:M&Aディール及び事業提携情報
    Summary ReWalk Robotics Ltd (ReWalk) is a medical device company that designs, develops and commercializes exoskeletons. The company provides walk restoration devices for people with lower limb disabilities to stand and walk once again. Its products include ReWalk personal system and ReWalk rehabili …
  • Zehnder Group AG (ZEHN):企業の財務・戦略的SWOT分析
    Zehnder Group AG (ZEHN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Saudi Industrial Export Company (4140):企業の財務・戦略的SWOT分析
    Summary Saudi Industrial Export Company (SIEC) is a chemical providing company that imports, exports and sales specialty chemicals, fertilizers, industrial materials and commodities. The company's fertilizers include diammonium phosphate, sulphur, urea, triple super phosphate, granular triple super …
  • Young & Co.’s Brewery, P.L.C. (YNGA):企業の財務・戦略的SWOT分析
    Young & Co.'s Brewery, P.L.C. (YNGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • AstraZeneca Plc (AZN)-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular and metabolic disease (CVMD); and cancer, besides autoimmune, infection and n …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆